期刊文献+

Ⅰ型变链素基因片段原核表达的构建 被引量:1

Prokaryotic expression of mutacin Ⅰ gene segments from Streptococcus mutan CH43
下载PDF
导出
摘要 目的:获得编码变形链球菌CH43变链素Ⅰ前体肽基因片段,构建Ⅰ型变链素的原核表达载体,优化表达条件。方法:实验于2004-09/2005-06在解放军第四军医大学秦都口腔医院牙体牙髓病实验室地点完成。①实验材料:streptococcusMutanCH43菌株由Dr.P.g.Caufield惠赠。E.coliTOP10E.coliDH5α及表达载体pProEX由秦都口腔医院牙体牙髓病实验室保存。②实验过程:厌氧条件下培养变形链球菌CH43,通过碱裂解法得到其基因组DNA。利用聚合酶链反应技术从变形链球菌CH43基因库中扩增出编码变链素Ⅰ前体肽mutA基因片段相应大小的DNA片段,将片段与pMD18-T载体连接后测序以检测序列正确性。将测序正确的I型变链素mutA按照BamHI和HindIII酶切位点克隆入原核表达载体pProEX-HTb,将连接产物转化入E.coliDH5α,挑出阳性克隆,以A600从0.406~1.666七个不同浓度,异丙基β-D硫代半乳糖苷(终浓度设成1.0,1.4,1.8,2.0,2.5mmol/L5个梯度)诱导表达重组的带有6个组氨酸标签的融合蛋白,诱导时间分别3,6,18h。③实验评估:观察mutA片段的扩增及序列测定结果;表达载体的构建结果;融合蛋白在大肠杆菌中的表达及表达条件的优化。结果:①聚合酶链反应获得的mutA序列与GenBank报道的一致(为147bp)。②Ⅰ型变链素的mutA基因片断被成功克隆入原核表达载体pProEX-HTb中,在A600达到1.000以上,异丙基β-D硫代半乳糖苷终浓度1.2mmol/L,30℃诱导6h,蛋白表达量较佳,稳定可重复。结论:成功克隆变形链球菌CH43变链素ⅠmutA基因片段,构建表达了Ⅰ型变链素的融合蛋白。 AIM: To obtain mutA (coding the prepromutacin Ⅰ ) gene segments of Streptococcus mutan CH43, construct a prokaryotic expression vector of this mut A fragment, and optimize the induced conditions for expressing the prokaryotic vector efficiently. METHODS: The experiment was completed at the Department of Operative Dentistry and Endodontics, Stomatology College of the Fourth Military Medical University of Chinese PLA from September 2004 to June 2005. ①Streptococcus mutan CH43 strain was donated by Dr.P.g.Caufield. E.coliTOP10, E.coli DH5α and pProEX were preserved by the same laboratory above. ②Genome DNA was obtained using alkaline lysis in accordance with the sequence of Streptococcus mutan CH43 cultured under anaerobic condition, and a distinct segment of mut A was amplified by polymerase chain reaction (PCR). Then the PCR product was inserted into pMD18-T vector, the recombinant plasmid was transformed into E.coli.DH5α, and two-stranded DNA was sequenced after screening. Afterwards the purified PCR products were subcloned into the sequencing vector pProEX-HTb in a certain direction BamHI/HinoⅢ digestion. After identification by PCR and enzyme digestion at A600 as different as 0.406-1.666, the selected positive clone containing the recombinant expression vector was induced by isopropy-β-D-thiogalactoside (IPTG) at the final concentrations of 1.0, 1.4, 1.8, 2.0, 2.5 mmol/L for 3, 6, 18 hours, expressing six histidine-labeled fusion protein.③Amplification and sequencing of mut A segment were detected; the expression vector was determined; the induced expression of fusion protein in E. coil and the induced condition were optimized. RESULTS: ①The length of PCR product (147 bp) was identical with that GenBank reported.②The mut A gene segments of Streptococcus mutan CH43 was cloned into the prokaryotic expression vector pProEX-HTb. The optimal induced condition for the expression included the final concentration of IPTG was 1.2 mmol/L at 30 ℃ for 6 hours with A600 over 1.000. CONCLUSION: The expression vectors containing the mutacin Ⅰ coding gene mutA of Streptococcus mutan CH43 are successfully constructed, and the fusion protein is also constructed.
出处 《中国组织工程研究与临床康复》 CAS CSCD 北大核心 2007年第46期9316-9318,共3页 Journal of Clinical Rehabilitative Tissue Engineering Research
  • 相关文献

参考文献9

  • 1Davies DG, Parsek MR, Pearson JP,et al. The involvement of cell-to-cell signals in the development of a bacterial biofilm.Science 1998,280(5361):295-298.
  • 2Qi F, Chen P, Caufield PW.Purification and biochemical characterization of mutacin I from the group I strain of Streptococcus mutans,CH43,and genetic analysis of mutacin I biosynthesis genes. Appl Environ Microbiol 2000,66(8):3221-3229.
  • 3Bekal-Si Ali S, Hurtubise Y, Lavoie MC, et al. Diversity of Streptococcus mutans bactenocins as confirmed by DNA analysis using specific molecular probes.Gene 2002,283(1-2):125-131.
  • 4Qi F, Chen P, Caufield PW. The group I strain of Streptococcus mutans,UA140, produces both the lantibiotic mutacin I and a nonlantibiotic bacteriocin, mutacin IV.Appl Environ Microbiol 2001,67(1): 15-21.
  • 5Hillman JD, Brooks TA, Michalek SM, et al. Construction and Characterization of an Effector Strain of Streptococcus mutans for Replacement Therapy of Dental Caries Infection and Imunity. Infect Immun 2000,68(2):543-549.
  • 6Krull RE, Chen P, Novak J, Kirk M, et al. Biochemical Structural Analysis of the LanUbioUc Mutacin II.J Biol Chem 2000,275(21): 15845-15850.
  • 7Qi F, Chen P, Caufield PW. Purification of Mutacin III from Group III Streptococcus mutans UA787 and Genetic Analyses of Mutacin III Biosynthesis Genes. Appl Environ Microbiol 1999,65(9):3880-3887.
  • 8Balakrishnan M, Simmonds RS, Tagg JR. Diverse Activity Spectra of Bacteriocin-Like Inhibitory Substances Having Activity against Mutans Streptococci.Caries Res 2001,35:75-80.
  • 9Novak J, Caufleld PW, Miller EJ. Isolation and biochemical characterization of a novel lantibiotic mutacin from streptococcus mutans.J Bacteriol 1994,176(14):4316-4320.

同被引文献18

  • 1石馨,倪龙兴,田宇,邝容.变形链球菌CH43变链素Ⅰ基因片段的克隆及表达[J].实用口腔医学杂志,2005,21(3):339-342. 被引量:3
  • 2李领,刘天佳,胡晓燕,杨柳,柳雯.变链素活性与变形链球菌基因多态性的关系研究[J].中国微生态学杂志,2007,19(3):253-255. 被引量:4
  • 3陈亮,倪龙兴,张虎明,陈喜华,童忠春.人工合成mutacin的抑菌活性研究[J].牙体牙髓牙周病学杂志,2007,17(6):333-336. 被引量:2
  • 4HALE J D,TING Y T,JACK R W,et al. Bacteriocin (mutacin) production by Streptococcus rnutans genome sequence reference strain UA159 :elucidation of the antimicrobial repertoire by genetic dissection [ J]. Appl Environ Microbio1,2005,71 ( 11 ) :7613-7617.
  • 5BALAKRISHNAN M, SIMMONDS R S, KILIAN M, et al. Different bacteriocin activities of Streptococcus mutans reflect distinct phylogenet- ic lineages[ J]. J Med Micrebiol,2002,51 ( 11 ) :941-948.
  • 6QI F, MERRITTJ, LUX R, et al. Inactivation of the ciaH Gene in Streptococcus mutans diminishes mutacin production and competence development, alters sucrose-dependent biofilm formation, and reduces stress tolerance[ J ]Infect Immun ,2004,72 (8) :4895 A899.
  • 7MOTA-MERIA M, LaPOINTE G, LACROIX C, et al. MICs of mutacin B-Ny266 ,nisin A, vancomycin, and oxacillin against bacterial pathogens[ J]. Antimicrob Agents Chemother,2000,44 ( 1 ) :24-29.
  • 8QI F, CHEN P, CAUFIELD P W. Purification of mutaein Ⅲ from group Ⅲ streptococcus rnutans UA787 and genetic analyses of mutacin Ⅲ biosynthesis genes [ J ]. Appl Environm Mierobiol, 1999, 65 ( 9 ) : 3880-3887.
  • 9HAMADA S, OOSHIMA T. Inhibitory spectrum of a bactefiocinlike substance (mutacin) produced by some strains of Streptococcus mutans [ J ]. J Dent Res, 1975,54 ( 1 ) : 140-145.
  • 10QI F, CHEN P, CAUFIELD P W. The group I strain of Streptococcus mutans, UA140, produces both the lantibiofic mutacin Ⅰ and a nonlantibiotic bacteriocin, mutacin Ⅳ[ J ]. Appl Environm Microbiol, 2001,67 (1) :15-21.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部